IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer - Dent, Rebecca; André, F.; Gonçalves, A.; Martin, M.; Schmid, P.; Schütz, Florian; Kümmel, S.; Swain, S. M.; Bilici, A.; Loirat, D.; Villalobos Valencia, R.; Im, S. -A.; et al. (Annals of oncology, 2024)
Online verfügbar: 15. Mai 2024, Artikelversion: 21. Juni 2024